Areas of Expertise

iX Syrinx has expertise in the following areas:

  • Formulation development of complementary, OTC and prescription products
  • Design of Phase I through to Phase IV clinical trials, including bioavailability and bioequivalence studies
  • Manufacture of oral and topical dose forms specialising in lyophilisation
  • Analytical method development and validation
  • Product registration for Australian and overseas markets e.g. United States, Canada, European Union and South East Asia
  • Licensed facilities that handle and distribute Controlled Medicines (including Schedule 8 and 9 Poisons)